Blog

Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Member organizations and others share their perspectives on a wide variety of topics relating to public and private sector research and innovation, and public health. The views expressed by contributors are their own and not the view of Research!America.

Recent Blog Posts

Dear Research Advocate, Research!America board member and APHA Executive Director Dr. Georges Benjamin addressed a recent alliance meeting, discussing three epidemics: COVID-19: Emerging infectious disease; Infodemic: Misinformation and disinformation; and Epidemic of Fear: Fear of the unknown, complicated by misstatements and poor risk communication by a range of actors in a rapidly moving communication environment. Dr. Benjamin emphasized the importance of correcting misinformation – not letting bad information go unchecked. He also suggested we talk about “physical” distancing rather than “social” distancing because being social is important to our health and well-being and shouldn’t be...
Dear Research Advocate, Jumping right in: Funding, Current and Future : Democratic Leaders in the House are focusing on the Moving Forward Framework , an infrastructure investment blueprint they originally released in January 2020, as the foundation for a fourth, $2 trillion supplemental. As it stands, both House Republicans and the Senate seem reluctant to pass another supplemental; nonetheless, the prospects for an infrastructure-focused stimulus are strong. We have heard that Congress and the administration may opt to roll FY21 funding into the aforementioned infrastructure supplemental rather than go the well-worn (and progress-stifling) “Continuing Resolution” route. While at this...
Dear Research Advocate, Congress is expected to pass a stimulus bill that includes significant investments in our nation’s key research agencies. The Coronavirus Aid, Relief and Economic Security (CARES) Act includes $27 billion to BARDA for critical medical supplies, personal protective equipment (PPE), and the manufacturing and purchase of vaccines and therapeutics; $4.3 billion to CDC for public health preparedness and response; $945 million to NIH for vaccine, therapeutic, and diagnostic research; $80 million to FDA for additional funding for vaccines, medical product manufacturing, and medical supply chain monitoring; and $75 million to NSF for research and grant programs related to...
Since our founding more than 30 years ago, a key strategy tool in Research!America's advocacy for science and medical research has been influencing public opinion. As President Abraham Lincoln said, “…public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.” Over our 28 years of commissioning surveys, Research!America has asked a wide variety of questions about the importance of scientists informing the public and elected officials about their research and its impacts. In January 2020, our survey asked: "How important is it for scientists to inform the public about their research and its impact on society?" In response, 9 in 10 Americans...
Dear Research Advocate, Because Research!America’s membership spans the ecosystem of stakeholders in research, we are fortunate to have access to a broad and comprehensive range of information you might find helpful. Visit and share our COVID-19 webpage. www.ResearchAmerica.org/COVID19 . A CDC report just out indicates that younger Americans have been hospitalized with COVID-19 at a higher rate than anticipated. As we look ahead to the use of vaccines against this and other threats, we have new (in the field just last evening) survey data showing that almost two-thirds of Americans ages 18-29 may not fully understand the role of vaccines. Better news is that this demographic is increasingly...
The Research!America team is working remotely as are many of you to take precautions against COVID-19. But we are certainly not slowing down. We are working hard to assure federal funding and policy actions are evidence-based and match the urgency needed to: Support the flexibility and funding research institutions need during this challenge. Capture and reflect back the essential role public and private sector fueled science is playing in addressing COVID-19. Promote completion of the FY21 appropriations process, critical to economic stability and strategic capacity going forward. We will continue to keep you updated about important advocacy opportunities and other valuable COVID-19-...
Dear Research Advocate, At this challenging time, Research!America is laser-focused on helping to advance policy and funding actions to speed the day we see the end of the COVID-19 pandemic. You will be hearing more from us as we share what we know, including ways you can get involved in advocacy at this important time. We invite you to be in touch with us with your suggestions. While we took the step of postponing one of our signature events — our Advocacy Awards Dinner — we look forward to announcing a new date. As we hit the “send” button, members of Congress and the White House are negotiating a supplemental budget package focused on mitigating the economic impact of the COVID-19...
March 8-14 is World Glaucoma Week 2020, with events being held around the globe. As one of those events, Research!America and AEVR are pleased to join in releasing the latest edition of the Vision and Blindness fact sheet , which provides useful information about eye disease and vision impairment, including the latest research into glaucoma. Americans fear vision loss more than most other medical conditions, as reported in a 2014 Research!America poll conducted for AEVR. Since glaucoma is the second leading cause of preventable vision loss in the United States, sustained education about the disease is vital as individuals often are unaware they have it until vision is lost. A neurological...
More than 9,000 scientists, educators, and journalists gathered in Seattle, February 13-16, 2020, for presentations, lectures, and networking at the American Association for the Advancement of Science (AAAS) Annual Meeting: “Envisioning Tomorrow’s Earth.” Sessions and discussions focused on climate change, biomedical and engineering advances, science advocacy and communication, and future health strategies. This was my third AAAS meeting and I arrived in Seattle having recently completed my PhD in biomedical science at The Rockefeller University. One session, titled “Science is Political, Not Partisan: Best Practices for Science Policy Advocates” was organized by the director of membership...
Dear Research Advocate, In their different ways, Super Tuesday and COVID-19 both speak to public sentiment. What are Americans’ expectations for those who represent them in Washington — and candidates who want to represent them in Washington — when it comes to promoting and protecting their best interests? A new Research!America-commissioned survey (in the field just days before COVID-19 captured worldwide public attention) found that Americans want their policymakers to consult with public health professionals and scientists; are deeply concerned about a diversity of public health issues affecting their families, their communities, and our nation as a whole; and believe there should be...

Pages

We have health challenges in this country that science will provide answers for if given the chance and we haven't given science that opportunity
Mary Woolley, President and CEO, Research!America